Gerresheimer & Bormioli Pharma make their first joint trade show appearance at Pharmapack 2025

Published: 22-Jan-2025

The companies will showcase their containment and primary packaging solutions, as well as their digital and drug delivery systems for the pharmaceutical market

Pharma systems and solutions provider Gerresheimer will present its portfolio of containment solutions, drug delivery systems and digital solutions with Bormioli Pharma for the first time at Pharmapack 2025.

At booth F55, the companies will be on hand to discuss the expanded portfolio of containment solutions following Gerresheimer's acquisition of Bormioli, as well as their range of specialised primary packaging solutions and delivery systems for sensitive biologics. 

Gerresheimer experts will also be available in the “Learning Lab” to provide insights into current trend topics.

In the Innovation Gallery, Gerresheimer will give a sneak preview of an exciting solution for adherence support in clinical trials using a digitally connected container for solid drugs. 
 
Under the motto "Two Stories - One Future", Gerresheimer and Bormioli Pharma are presenting together at Pharmapack for the first time, after Gerresheimer’s successful completion of the Bormioli Pharma acquisition in December 2024.

Pharmaceutical companies will benefit from an even wider range of containment solutions with suitable closure options and accessories, sustainable product lines and the combined innovative strength of both companies.
 

Comprehensive biologic solutions

The focus of the trade show appearance will be on primary packaging solutions specially tailored to the requirements of sensitive biologics. With Gx Elite syringes, cartridges and vials, for example, Gerresheimer offers the highest quality and the best protection for injectable drugs.

With EZ-fill Smart, Gerresheimer presents the next generation packaging platform for ready-to-fill (RTF) primary packaging such as vials and cartridges.

Both the outstanding product quality of the Gx Elite Performance Level and the innovative new packaging platform are designed to provide the best possible protection for particularly sensitive and expensive drugs such as novel biologics and to enable efficient, smooth filling. 
 

Addressing patient centricity

With the Gx Inbeneo auto-injector and the Gx SensAir on-body drug delivery device, Gerresheimer is also addressing the trend towards home therapy. Both devices enable simple, patient-friendly application with high-precision dosing of the respective medication. The on-body drug delivery device can optionally be digitally connected and integrated into digital health platforms. 
 

A sneak-peek: Gx Cap for adherence support in clinical trials

In the Innovation Gallery (F12), Gerresheimer will provide a first glimpse at an exciting new digital solution for adherence support in clinical trials. Sueyoung Yoon (Gerresheimer) will briefly present the solution on January 23 at 11:40AM in the Innovation Gallery: Adherence to therapy is crucial to the success of clinical trials. If medication is not taken as intended, this could affect data integrity, trial efficiency and the safety of trial participants.

Gx Cap for Clinical Trials is a digitally connected tablet container cap, which enables the monitoring of oral medication intake so that trial participants can be reminded to take their medication if necessary. Gx Cap is already being used successfully by pharmacies in the USA for remote therapeutic monitoring programs for certain therapeutic areas.
 

Learning lab highlights

Gerresheimer will also be give two presentations in the Learning Lab and the Sustainability Theater on the 23 Jan, providing insights and expertise to its fellow industry members. These include: 
 

  • A Partnership Worth More Than the Sum of Its Parts - Device Component Manufacturers Fulfil Syringe and System Performance Requirements (January 23, 2025, 10:10 - 10:40AM, Learning Lab K3, Speakers: Sébastien Cordier (Aptar Pharma), Lucy Lee (SHL Medical), Bernd Zeiss (Gerresheimer))
     
  • The innovation journey: Developing EZ-fill Smart as the New Industry Standard for Ready-to-Use Vials (January 23, 2025, 2:30 - 3:00PM, Learning Lab K3, Speaker: Holger Krenz (Gerresheimer))

 

 

You may also like